Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses [Phase 2]
A Phase 2 trial assessing teriflunomide for relapsing multiple sclerosis has completed, with reported safety and efficacy outcomes.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: REbif FLEXible Dosing in Early Multiple Sclerosis (MS) [Phase 3]
Phase 3 clinical trial update evaluating flexible dosing of REBIF (interferon beta-1a) in early multiple sclerosis. Results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis [Phase 3]
A Phase 3 parallel-group study compared Sativex with placebo for detrusor overactivity in patients with multiple sclerosis; the trial is com…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients [Phase 3]
Phase 3 clinical trial investigating THC and CBD in multiple sclerosis has completed; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis [Phase 3]
Phase 3 clinical trial investigating Sativex for central neuropathic pain in multiple sclerosis has completed with results posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating THC and CBD in multiple sclerosis completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. [Phase 3]
Phase 3 clinical trial update for Sativex® in relief of spasticity in multiple sclerosis; trial completed with results posted.
-
FDA approval · 2012-09-12FDA Approved: AUBAGIO — Original Application (Genzyme Corporation)
FDA approved Aubagio (teriflunomide) from Genzyme in its original application for the treatment of relapsing forms of multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Motor Training and White Matter in Multiple Sclerosis (MS) [NA]
A clinical trial investigating motor training and white matter in multiple sclerosis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
Long-term study update of fingolimod in multiple sclerosis from the FTY clinical program; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients [Phase 4]
This Phase 4 trial evaluating the combination of interferon beta and vitamin D in relapsing-remitting multiple sclerosis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis [NA]
A completed clinical trial evaluated the effect of Transcutaneous Electrical Nerve Stimulation (TENS) in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Study on Cognitive Disorders of Multiple Sclerosis [Phase 3]
Phase 3 clinical trial on cognitive disorders associated with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin [Phase 3]
Phase 3 clinical trial assessing a cannabis-based medicine for pain of neurological origin, completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: A Study of the Long-term Safety of Sativex Use [Phase 3]
Long-term safety study update for Sativex in multiple sclerosis patients with spasticity (Phase 3; completed; results posted).
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis [Phase 3]
Long-term safety extension study of THC/CBD in multiple sclerosis has completed Phase 3 with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating the efficacy of Sativex for relieving spasticity symptoms in multiple sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance
Biogen's AVONEX preventive study in high-risk multiple sclerosis participants has been terminated and is under ongoing neurological surveill…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Early Cognitive Impairment in Multiple Sclerosis
A completed clinical trial evaluating early cognitive impairment in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Experimental Evaluation of Wheelchair-Mounted Robotic Arms
This update covers the completion of a clinical trial evaluating wheelchair-mounted robotic arms. The trial included participants with spina…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain [Phase 3]
A Phase 3 trial compared pregabalin with paroxetine for management of neuropathic pain due to multiple sclerosis and has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis [Phase 4]
This document reports the completion of a Phase 4 trial evaluating nabilone as an adjunct to gabapentin for neuropathic pain in multiple scl…
-
FDA label_change · 2012-07-20FDA Approved: AMPYRA — Supplemental Application (Merz Pharmaceuticals, LLC)
FDA approved a supplemental application for AMPYRA (dalfampridine) submitted by Merz Pharmaceuticals, resulting in an update to the drug's l…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]
This report presents long-term efficacy and safety data for fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis from…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS [Phase 3]
A Phase 3 trial evaluating Sativex added to existing therapy for central neuropathic pain in people with multiple sclerosis; results of the …